{
  "thread": {
    "uuid": "8df027e68dab6e7bd5bb6fdbe7808088e6377750",
    "url": "https://www.prnewswire.com/news-releases/la-fda-aprueba-un-nuevo-antibiotico-para-tres-usos-distintos-850842700.html",
    "site_full": "www.prnewswire.com",
    "site": "prnewswire.com",
    "site_section": "https://prnewswire.com/news-releases/photos/photos-list",
    "site_categories": [
      "media"
    ],
    "section_title": "All Photos News from PR Newswire",
    "title": "La FDA aprueba un nuevo antibiótico para tres usos distintos",
    "title_full": "La FDA aprueba un nuevo antibiótico para tres usos distintos",
    "published": "2024-04-04T21:27:00.000+03:00",
    "replies_count": 0,
    "participants_count": 1,
    "site_type": "news",
    "country": "US",
    "main_image": "https://mma.prnewswire.com/media/317925/FDA_Logo.jpg?p=facebook",
    "performance_score": 0,
    "domain_rank": 191,
    "domain_rank_updated": "2024-04-02T13:08:08.000+03:00",
    "reach": null,
    "social": {
      "facebook": {
        "likes": 0,
        "comments": 0,
        "shares": 0
      },
      "gplus": {
        "shares": 0
      },
      "pinterest": {
        "shares": 0
      },
      "linkedin": {
        "shares": 0
      },
      "stumbledupon": {
        "shares": 0
      },
      "vk": {
        "shares": 0
      }
    }
  },
  "uuid": "8df027e68dab6e7bd5bb6fdbe7808088e6377750",
  "url": "https://www.prnewswire.com/news-releases/la-fda-aprueba-un-nuevo-antibiotico-para-tres-usos-distintos-850842700.html",
  "ord_in_thread": 0,
  "parent_url": null,
  "author": "U.S. Food and Drug Administration",
  "published": "2024-04-04T21:27:00.000+03:00",
  "title": "La FDA aprueba un nuevo antibiótico para tres usos distintos",
  "text": "In English SILVER SPRING, Md., 4 de abril de 2024 /PRNewswire-HISPANIC PR WIRE/ — Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) ha aprobado Zevtera (ceftobiprol medocaril sódico inyectable) para el tratamiento de adultos con…\nSource link",
  "highlightText": "",
  "highlightTitle": "",
  "highlightThreadTitle": "",
  "language": "spanish",
  "sentiment": "positive",
  "categories": [
    "Health"
  ],
  "external_links": [
    "https://c212.net/c/link/?t=0&l=es&o=4134138-1&h=3201433668&u=https%3A%2F%2Fwww.fda.gov%2Fnews-events%2Fpress-announcements%2Ffda-approves-new-antibiotic-three-different-uses&a=In+English",
    "https://c212.net/c/link/?t=0&l=es&o=4134138-1&h=3002795324&u=https%3A%2F%2Fclinicaltrials.gov%2Fstudy%2FNCT00326287&a=estudio",
    "https://c212.net/c/link/?t=0&l=es&o=4134138-1&h=2878173502&u=https%3A%2F%2Fwww.fda.gov%2FEspanol&a=www.FDA.gov%2F",
    "https://c212.net/c/link/?t=0&l=es&o=4134138-1&h=1922420250&u=https%3A%2F%2Fwww.fda.gov%2FEspanol&a=Espanol",
    "https://c212.net/c/link/?t=0&l=es&o=4134138-1&h=345627293&u=https%3A%2F%2Fwww.fda.gov%2Fnews-events%2Fpress-announcements%2Fla-fda-aprueba-un-nuevo-antibiotico-para-tres-usos-distintos&a=aprobado",
    "https://c212.net/c/link/?t=0&l=es&o=4134138-1&h=2120478660&u=https%3A%2F%2Fclinicaltrials.gov%2Fstudy%2FNCT03137173&a=estudio",
    "https://c212.net/c/link/?t=0&l=es&o=4134138-1&h=181928475&u=https%3A%2F%2Fwww.clinicaltrials.gov%2Fstudy%2FNCT03439124&a=estudio",
    "https://c212.net/c/link/?t=0&l=es&o=4134138-1&h=3775414118&u=https%3A%2F%2Fclinicaltrials.gov%2Fstudy%2FNCT03138733&a=estudio",
    "https://c212.net/c/link/?t=0&l=es&o=4134138-1&h=3859612342&u=https%3A%2F%2Fwww.fda.gov%2Femergency-preparedness-and-response%2Fmcm-issues%2Fantimicrobial-resistance-information-fda&a=Informaci%C3%B3n+sobre+la+resistencia+a+los+antimicrobianos+de+la+FDA",
    "https://www.c212.net/c/link/?t=0&l=es&o=4134138-1&h=3775414118&u=https%3A%2F%2Fclinicaltrials.gov%2Fstudy%2FNCT03138733&a=estudio",
    "https://www.c212.net/c/link/?t=0&l=es&o=4134138-1&h=3201433668&u=https%3A%2F%2Fwww.fda.gov%2Fnews-events%2Fpress-announcements%2Ffda-approves-new-antibiotic-three-different-uses&a=In+English",
    "https://www.c212.net/c/link/?t=0&l=es&o=4134138-1&h=2878173502&u=https%3A%2F%2Fwww.fda.gov%2FEspanol&a=www.FDA.gov%2F",
    "https://www.c212.net/c/link/?t=0&l=es&o=4134138-1&h=345627293&u=https%3A%2F%2Fwww.fda.gov%2Fnews-events%2Fpress-announcements%2Fla-fda-aprueba-un-nuevo-antibiotico-para-tres-usos-distintos&a=aprobado",
    "https://www.c212.net/c/link/?t=0&l=es&o=4134138-1&h=1922420250&u=https%3A%2F%2Fwww.fda.gov%2FEspanol&a=Espanol",
    "https://www.c212.net/c/link/?t=0&l=es&o=4134138-1&h=181928475&u=https%3A%2F%2Fwww.clinicaltrials.gov%2Fstudy%2FNCT03439124&a=estudio",
    "https://www.c212.net/c/link/?t=0&l=es&o=4134138-1&h=3002795324&u=https%3A%2F%2Fclinicaltrials.gov%2Fstudy%2FNCT00326287&a=estudio",
    "https://c212.net/c/link/",
    "https://www.c212.net/c/link/?t=0&l=es&o=4134138-1&h=2120478660&u=https%3A%2F%2Fclinicaltrials.gov%2Fstudy%2FNCT03137173&a=estudio",
    "https://www.c212.net/c/link/?t=0&l=es&o=4134138-1&h=3859612342&u=https%3A%2F%2Fwww.fda.gov%2Femergency-preparedness-and-response%2Fmcm-issues%2Fantimicrobial-resistance-information-fda&a=Informaci%C3%B3n+sobre+la+resistencia+a+los+antimicrobianos+de+la+FDA"
  ],
  "external_images": [],
  "entities": {
    "persons": [],
    "organizations": [],
    "locations": []
  },
  "rating": null,
  "crawled": "2024-04-05T01:29:34.947+03:00",
  "updated": "2024-04-05T04:24:54.096+03:00"
}